HEALTH TECHNOLOGY

Signify Health Projects Growth with its Partners in the BPCI Advanced Program

Signify Health | December 21, 2020

Signify Health, a leading worth based healthcare stage enabled by advanced examination, innovation and cross country healthcare networks, today reported that its supplier accomplices in the Center for Medicare and Medicaid Innovation (CMMI) Bundled Payment for Care Improvement Advanced (BPCI-A) program have chosen a bigger arrangement of packs to take an interest in for the rest of the program (2021-2023) than they did in 2020. Signify Health's experience and input from suppliers show that obligation to the program stays solid.

 

"The world has changed a lot since 2013 when a group of providers accepted CMMI's invitation to try a radically different approach to better coordinate care and reduce expenditures while improving the quality of that care," said Kyle Armbrester, Signify Health CEO. "Fast forward to today and these early pioneers are leaning in and fueling the next phase of growth with new entrants, including commercial plans and employers. Thanks to CMMI's work to lay the foundation, we have a proven model that both government and commercial payors can use to accelerate the transformation from fee-for-service to value-based care."

 

As a danger sharing convener in the BPCI-A program, Signify Health accomplices with Acute Care Hospitals (ACHs) and Physician Group Practices (PGPs) to encourage joint effort among suppliers sharing responsibility for improving results. As scenes of care keep on grabbing hold in broad daylight and private worth based health programs, Signify foresees the complete volume of clinical consideration oversaw through groups will quicken.

 

In a huge change from earlier years for the rest of the BPCI-A program, CMMI expected members to choose from eight classifications of care, alluded to as clinical help line groupings, that each incorporate different packs. In general, Signify's supplier accomplices chose more clinical packs under the new necessity, expecting a more prominent measure of monetary danger while guaranteeing that patients keep on getting excellent consideration.

 

Whenever groups are chosen, Signify Health's group works with suppliers to forestall unfavorable occasions, improve care quality, kill overabundance cost, and push quiet recuperation toward home by applying a model that tends to patients' all encompassing clinical, social, and conduct needs. Furthermore, by giving complex investigation, demonstrating and profound nearby market experiences, Signify upholds BPCI-A members' consideration overhaul endeavors to improve a patient's consideration venture from clinic release to home.

 

To additionally educate the future regarding scene of care installment programs in Medicare, Signify Health as of late drew in Leavitt Partners to meet an autonomous board of health strategy specialists to offer approach suggestions that fortify and extend these models. The proposals radiating from this warning cycle will be made freely accessible in the main quarter of 2021.

 

"For voluntary alternative payment programs to be successful, they must attract as many participants as possible," added Armbrester. "We believe that policies that minimize uncertainty and offer pricing stability for providers accepting financial risk are critical to the program's continued and long-term success."

 

Signify is expanding on its involvement with the BPCI-A program to plan scenes of care programs that address the issues of business health plans, for example, Regence, and bosses, for example, the State of Connecticut. Signify can offer an assortment of scene compromise and installment alternatives to oblige the shifting requirements and capacities of payors and suppliers. For instance, the organization's new procurement of PatientBlox will quicken the Company's planned supplier installment abilities by utilizing blockchain innovation.

 

About Signify Health

Signify Health is a leading healthcare platform that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs. Our mission is to transform how care is paid for and delivered so that people can enjoy more healthy, happy days at home. Our solutions support value-based payment programs by aligning financial incentives around outcomes, providing tools to health plans and healthcare organizations designed to assess and manage risk and identify actionable opportunities for improved patient outcomes, coordination and cost-savings. Through our platform, we coordinate what we believe is a holistic suite of clinical, social, and behavioral services to address an individual's healthcare needs and prevent adverse events that drive excess cost, all while shifting services towards the home.

Spotlight

The promise of healthcare technology is to prevent illness in high-risk patients. David Dirks of Castell Health and Arcadia’s Michael Meucci reflect.


Other News
FUTURE OF HEALTHCARE

Radius XR™ Named as the CES 2023 Innovation Award Honoree for Wearable Device That Combines Therapy and Diagnostic Capabilities

Radius XR | November 17, 2022

Today at the CES Unveiled New York event, Radius XR™, a new fashion-forward wearable healthcare technology brand, was named a CES® 2023 Innovation Awards Honoree in both the Digital Health and Virtual & Augmented Reality categories. Radius was selected from among a record number of submissions to this year’s CES Innovation Awards program. The announcement was made ahead of CES 2023, the influential technology event, happening Jan. 5-8 in Las Vegas, NV. Radius XR builds on the therapeutic legacy of IrisVision, a leader in digital vision technologies and itself a 2019 CES Innovation Winner. The Radius proprietary XR assistive device brings together—for the first time—multimodal diagnostics, practice management, and patient engagement. “This is a tremendous honor for our new company. It follows on the success of our IrisVision visual assistive device, which has provided a life-changing solution for thousands of individuals living with legal blindness and low-vision conditions. Radius expands on our commitment to vision health by providing the eyecare industry with an easy-to-use wearable device capable of performing standard perimetry tests. Other exams include color vision, visual acuity, contrast sensitivity—a comprehensive suite of standard vision tests. Development of additional exams is ongoing.” Radius founder and CEO Ammad Khan Radius enables patients to quickly and easily conduct vision tests with minimal guidance or intervention by the staff. The device’s RadiusExam® software and proprietary algorithms provide diagnostic testing results equivalent to current exam gold standards. “By designing our own hardware and software, we’re able to overcome many of the challenges inherent in the off-the-shelf headsets already on the market. Matching visual field strategies, background luminance, stimulus size and dynamic range allows us to mirror the current standards, making it easy and intuitive for clinicians to transition to Radius,” said John Trefethen, Radius Chief Marketing Officer. In addition, the included Business Suite helps clinicians manage everyday aspects critical to their practice's ongoing success. Features like patient education, staff training and clinician onboarding are now possible inline with the Radius platform. Radius is the industry’s lightest wearable device and has the look and feel of a pair of stylish sunglasses. The compact, lightweight design overcomes the challenges of expensive and bulky legacy devices that force patients to sit in uncomfortable positions for testing. With Radius, exams can be conducted anywhere, even in the waiting room, eliminating the need to shuttle patients between machines, which can be challenging for individuals with mobility or vision issues. The CES Innovation Awards program, owned and produced by the Consumer Technology Association (CTA)®, is an annual competition honoring outstanding design and engineering in 27 consumer technology product categories. Those with the highest rating receive the “Best of Innovation” distinction. An elite panel of industry expert judges, including members of the media, designers, engineers and more, reviewed submissions based on innovation, engineering and functionality, aesthetics, and design. The CES 2023 Innovation Awards honorees, including product descriptions and photos, can be found at CES.tech/innovation. Radius will be on display at the Innovation Awards Showcase at CES 2023 in Las Vegas in January. About Radius XR The Radius XR platform is a portable vision diagnostic and patient engagement system that combines medical-grade diagnostics, business management, and patient education tools in a single wearable XR device. The RadiusExam® and proprietary algorithms provide diagnostic testing results equivalent to current exam gold standards, with the clinical science validated by Deming regression. As the algorithm presents stimuli to patients, it adapts to responses to maximize the algorithm's speed. The total hardware and software system helps medical professionals diagnose patients with accuracy, grow their eyecare practices, enhance patient engagement, and reduce staff workload by enabling patients to perform self-guided vision exams with minimal supervision.

Read More

MEDICAL DEVICES

Carestream Health Unveils New X-ray Detectors, Enhanced X-ray Rooms at World’s Largest Radiology Exhibition

Carestream Health | November 29, 2022

Carestream’s legacy of delivering quality medical imaging technology continues with the launch of new digital X-ray detectors that help improve clinical outcomes, while enhancements to its existing product portfolio reflect the company’s deep understanding of the radiology profession. At the annual meeting of the Radiological Society of North America (RSNA) in Chicago, the company is displaying its expanding portfolio of medical imaging systems that provide quantifiable benefits to healthcare organizations and their patients, including New Carestream Focus HD 35 and Focus HD 43 detectors that offer higher resolution with a 100 micron pixel pitch that allows for image magnification for better visibility of small objects and microstructures. The detectors’ Cesium (CsI) scintillator is ideal for dose-sensitive pediatric patients; and the detectors have an IP56 rating for better protection against dust and fluid ingress. Next generation of long-length imaging, the Carestream DRX-LC Detector (INVESTIGATIONAL – NOT AVAILABLE FOR COMMERCIAL SALE) captures long-bone and spine images with a single exposure, making it ideal for pediatric imaging and long-bone and spine images of people with limited mobility. In contrast, the traditional multi-shot approach requires three to five exposures followed by manipulation and stitching of the images. The new detector is designed to capture the full image in a single exposure to minimize dose and mitigate motion artifact that can appear from patient movement with a multi-shot exam. The DRX-LC Detector is designed with X-Factor so the detector can be shared across different Carestream X-ray systems and is compatible with both rooms and mobile units. Enhancements to the Carestream DRX-Evolution Plus that provide improved patient comfort and a better ergonomic experience along with improved workflow for the radiographer. Its new tabletop design eliminates rails that can cause strain and discomfort for both radiographer and patient, enabling patients to be moved more smoothly and with less effort to the exam table. New features in the Carestream DRX-Excel Plus provide a better staff experience with faster workflow and better diagnostic image quality. Designed specifically for large and mid-size hospitals and medical centers, this innovative system combines fluoroscopy and general radiology capabilities in one compact unit. It delivers accelerated workflow, high-resolution images and a wide range of patient exam options. “Our commitment to quickly respond to the needs of the radiology community with ideas that clearly work is as strong as ever, and we are solidly positioned to continue developing solutions that have quantifiable benefits to our customers and their patients. Organizations can have complete confidence in our ability to provide high-value technology that helps lower costs, and improves imaging workflow for radiology departments, technologists and other healthcare professionals—all with the goal of improving patient care.” David C. Westgate, Chairman, President and CEO of Carestream About Carestream Health Carestream is a worldwide provider of medical imaging systems; X-ray imaging systems for non-destructive testing; and precision contract coating services for a wide range of industrial, medical, electronic and other applications—all backed by a global service and support network.

Read More

DIGITAL HEALTHCARE, MEDICAL DEVICES

Swisslog Healthcare Elevates Cory Kwarta to CEO

Swisslog Healthcare | December 19, 2022

Swisslog Healthcare, a leading supplier in healthcare technology solutions of both medication management and transport automation, has appointed Cory Kwarta as its CEO. Kwarta, who was appointed as CEO of the Swisslog Healthcare – TransLogic division earlier this year, is now entrusted to oversee the global organization, guiding both the company’s TransLogic® and Medication Management divisions. “Since I started at Swisslog Healthcare, my goal has always been to help improve efficiencies in the healthcare industry. As CEO of the company, I will remain dedicated to our organization’s commitment of helping our customers and partners provide the highest quality healthcare.” Cory Kwarta Cory Kwarta was also recently named as a member of Swisslog Healthcare’s Board of Directors. The move came as a result of Kwarta’s recent prior promotion to CEO of Swisslog Healthcare – TransLogic and his 15 years of service with the organization. Kwarta has a bachelor’s degree in systems engineering from the United States Military Academy at West Point and a master’s degree in business administration from the University of Denver. Swisslog Healthcare’s TransLogic division works with healthcare facilities to develop custom-designed pneumatic tube systems which automate their needs to transport materials from station to station. The Medication Management division of Swisslog Healthcare assists healthcare facilities with automating and managing the pharmaceutical workflow, including preparation, patient-specific dosing, delivery, and storage. Both divisions deliver operational cost reduction by enabling the redeployment of personnel to patient-facing activities. About Swisslog Healthcare Swisslog Healthcare provides integrated medication supply chain solutions to hospitals and health systems to assist providers in treating patients across the continuum of care. Integrating transport and pharmacy automation, value-added services, and intelligent software, Swisslog Healthcare enables healthcare providers to respond to patient’s needs quickly and with greater accuracy. The company minimizes many sources of operational waste, so providers achieve higher levels of productivity to impact the well-being of patients in positive ways.

Read More

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

Juno Medical Raises $12M Series A Led by NEXT VENTURES and Serena Ventures; Funding Will Fuel Juno's National Expansion

Juno Medical | December 12, 2022

Juno Medical, the modern doctor's office that's designed for the 99%, today announced $12 million in Series A funding co-led by Julian Eison, Managing Partner at NEXT VENTURES, and Serena Williams, Managing Partner at Serena Ventures. Juno’s comprehensive tech-enabled healthcare model is designed to meet the everyday healthcare needs of "the 99%,” with a specific focus on revitalizing neighborhoods across the United States and delivering a beautiful environment, transparent pricing, and exceptional care. The funding will support Juno’s continued development of its technology platform and expansion into new markets, including Atlanta, Georgia, Tulsa, Oklahoma, and Los Angeles, California. Other notable participants include Vast Ventures, which led Juno’s seed round, Empire State Development’s New York Ventures, TXV Partners, Genius Guild, Gaingels, and previous investors Atento Capital and Humbition. Juno’s team has unmatched healthcare, technology, and business expertise. Juno Founder and CEO Dr. Akili Hinson’s background spans medicine and business. He is a physician by training and former McKinsey & Company consultant with expertise in payment innovation, value-based care delivery, and digital transformation. Juno’s medical leadership team includes Chief Health Officer Dr. Aarti Agarwal, an internist and epidemiologist with expertise in global health and value-based care, as well as Juno’s two founding physicians, Dr. Shante Hinson, a rheumatologist and preventative health expert dedicated to bridging the healthcare gap in underserved communities, and Dr. Candice Fraser, an OB/GYN with over a decade of experience as a trusted guide in women's health. “Juno’s vision is to reimagine the future of healthcare by finally making exceptional, family-centered care accessible and affordable for the 99% all across the United States. At Juno, we’ve designed healthcare that people love by providing the highest quality care and incredible service in a beautiful environment that feels like a place to belong—all powered by modern technology. We are honored by the support of the thousands of patients who have trusted us with their care and our investors who believe in us — we could not be more excited to bring Juno to more neighborhoods and communities all across the country.” Dr. Akili Hinson Juno’s products and services are designed for the family’s “Chief Caregiver” by bringing the best of primary care, pediatrics, women's health, same-day care, and virtual care into one thoughtfully designed experience. “It brings joy to my heart knowing Juno is on a mission to bring exceptional healthcare to cities and developing areas of our nation where suboptimal care, facilities, and services have been tolerated out of necessity for way too long," said Julian Eison, Managing Partner of NEXT VENTURES. “I believe Juno’s hybrid approach leveraging brick and mortar clinics paired with digital access is an enduring model that will serve as the fundamental basis to build community trust and outcomes to match. It’s an honor to have partnered with such an esteemed team, attacking one of the largest problems of our time.” Juno accelerated the opening of its first location in the Harlem neighborhood of New York City to see patients in April 2020 when the COVID-19 pandemic devastated New York and many physician offices were closed. In addition to providing COVID testing and care to hundreds of residents, Juno continued to offer in-person preventive care during the pandemic which led to the identification of treatable cancers and previously undiagnosed chronic conditions in asymptomatic women and men — which may have been missed in the absence of the founding team’s commitment to serve. “We are honored to partner with Juno to expand upon their inclusive, full-service healthcare home model where people from all backgrounds feel seen, heard and welcome,” said Serena Williams, Managing Partner of Serena Ventures. “There is a serious need to address equity issues in healthcare, mental health and wellness services that many communities face. Juno and its talented team have the vision, model and track record to disrupt the unacceptable status quo in healthcare.” Juno’s approach and presence in underserved communities is part of the solution to a growing challenge of healthcare disparities that exist across the United States. A recent report from the Kaiser Family Foundation outlined race-based disparities in maternal and infant health and mortality. The markets in which Juno will expand have their own unique health care challenges. On November 1, Atlanta Medical Center closed its doors, leaving an already-strained healthcare system with one less option and exacerbating concerns about the future of safety net hospitals in the region and state. In North Tulsa, where Juno’s clinic will be located, residents have a life expectancy 13 years shorter than their neighbors in South Tulsa. “Empire State Development’s New York Ventures exists to partner with promising startups that are working to solve the world’s most important challenges, and we are proud to support Juno Medical as they strive to provide exceptional healthcare to New Yorkers, especially in areas that are often overlooked or left behind,” said Hope Knight, President, CEO and Commissioner of Empire State Development. “Juno’s success in New York State is a road map for the future and a proven model for delivering quality, affordable healthcare for all.” Unlike recent trends in concierge medicine and digital health, Juno’s model is designed to work with nearly all types of insurance—including commercial plans, Medicare and Medicaid—without initial barriers or exclusive membership fees. Juno is taking a different approach to meet the needs of busy households by offering additional plans that start at $20 per month per person or $50 per month per family that complement its core services with added conveniences like night and weekend appointments, savings, and unique events and experiences. Juno’s hybrid model includes both in-person options for patients and a robust e-health platform, which includes an app that allows patients to make appointments, manage care information, and keep in touch with their care team. As part of its mission to create a healthier world, Juno will use this funding to expand into new markets and recruit the highest-caliber provider talent in Atlanta, Tulsa and Los Angeles. Juno’s new clinics will be located in the historic yet overlooked neighborhoods of East Atlanta, Greenwood (Tulsa), and Inglewood (Los Angeles). The funding will also support the continued expansion of Juno’s robust technology platform for both patients and healthcare providers—a critical component of Juno’s innovative model. About Juno Medical Launched in April 2020, Juno Medical is a tech-enabled healthcare service provider designed for you and yours. The company offers exceptional hospitality, modern technology, and transparent prices that won't break the bank and brings the best of adult primary care, pediatrics, women's health, and same-day care into one thoughtful and beautifully designed place.

Read More

Spotlight

The promise of healthcare technology is to prevent illness in high-risk patients. David Dirks of Castell Health and Arcadia’s Michael Meucci reflect.

Resources